Zacks Investment Research on MSN24m
Novo Nordisk Lowers Wegovy Costs for Cash-Pay Patients, Stock Up 4%Novo Nordisk NVO announced that it is launching a new direct-to-patient online pharmacy called NovoCare, which will offer its ...
Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of ...
Elsewhere in the obesity space — Amgen has initiated Phase 3 trials of its obesity drug MariTide, one in overweight and obese people without diabetes and another one for people with diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback